A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Ipilimumab or Cabozantinib in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1, PHASE2

מצבים רפואיים

Advanced Renal Cell Carcinoma (RCC)

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Local Institution - 0178, Palo Alto, California, United States

  • Local Institution - 0117, New Haven, Connecticut, United States

  • Sibley Memorial Hospital, Washington D.C., District of Columbia, United States

    Contact: Study coordinator (Yasser Ged) · 410-570-9410
  • Local Institution - 0177, Miami, Florida, United States

  • Local Institution - 0126, Orlando, Florida, United States

  • Local Institution - 0175, Atlanta, Georgia, United States

  • Local Institution - 0170, Fort Wayne, Indiana, United States

  • Local Institution - 0124, Iowa City, Iowa, United States

  • Johns Hopkins Hospital, Baltimore, Maryland, United States

    Contact: Study coordinator (Yasser Ged) · 410-570-9410
  • Local Institution - 0176, Big Rapids, Michigan, United States

  • Washington University School of Medicine, St Louis, Missouri, United States

    Contact: Study coordinator (Melissa Reimers) · 314-362-5740
  • Memorial Sloan Kettering Cancer Center, Hauppauge, New York, United States

    Contact: Study coordinator (Sahil Doshi)
  • Local Institution - 0135, Cincinnati, Ohio, United States

  • Cleveland Clinic, Cleveland, Ohio, United States

    Contact: Study coordinator (Moshe Ornstein) · 216-445-6592
  • MUSC Hollings Cancer Center, Charleston, South Carolina, United States

    Contact: Study coordinator (Thai Ho) · 843-792-9300
  • Carolina Urologic Research Center, LLC, Myrtle Beach, South Carolina, United States

    Contact: Study coordinator (Neal Shore) · 843-449-1010
  • Local Institution - 0158, Salt Lake City, Utah, United States

  • Local Institution - 0095, Seattle, Washington, United States

  • Local Institution - 0154, Buenos Aires, Argentina

  • Local Institution - 0156, Buenos Aires, Argentina

  • Macquarie University, North Ryde, New South Wales, Australia

    Contact: Study coordinator (Howard Gurney) · +61298123526
  • GenesisCare St Leonards, St Leonards, New South Wales, Australia

    Contact: Study coordinator (Laurence Krieger) · 61294631172
  • Local Institution - 0011, Herston, Queensland, Australia

  • Local Institution - 0074, South Brisbane, Queensland, Australia

  • Local Institution - 0003, Malvern, Australia

  • Hospital Sirio Libanes, Brasília, Federal District, Brazil

    Contact: Study coordinator (Hernan Cutuli) · 5491157654803
  • Local Institution - 0007, Calgary, Alberta, Canada

  • Local Institution - 0109, Montreal, Quebec, Canada

  • Local Institution - 0009, Montreal, Quebec, Canada

  • Local Institution - 0105, Santiago, Santiago Metropolitan, Chile

  • Bradfordhill, Santiago, Santiago Metropolitan, Chile

    Contact: Study coordinator (Carlos Rojas) · +56998744662
  • Local Institution - 0163, Santiago, Chile

  • Local Institution - 0143, Beijing, Beijing Municipality, China

  • Local Institution - 0157, Beijing, Beijing Municipality, China

  • Local Institution - 0182, Guangzhou, Guangdong, China

  • Local Institution - 0183, Changsha Shi, Hunan, China

  • Local Institution - 0184, Nanjing, Jiangsu, China

  • Local Institution - 0188, Shanghai Shi, Shanghai Municipality, China

  • Local Institution - 0144, Beijing, China

  • Local Institution - 0052, Cali, Colombia

  • Local Institution - 0147, Prague, Praha 5, Czechia

  • Local Institution - 0149, Brno, Czechia

  • Local Institution - 0150, Hradec Králové, Czechia

  • Local Institution - 0044, Helsinki, Etelä-Suomen Lääni, Finland

  • Local Institution - 0029, Turku, Finland

  • Local Institution - 0060, Vantaa, Finland

  • Local Institution - 0083, Lille, Nord, France

  • Local Institution - 0080, Boredeaux, France

  • Local Institution - 0028, Villejuif, France

  • Local Institution - 0025, Jena, Thuringia, Germany

  • Local Institution - 0026, Hamburg, Germany

  • Local Institution - 0014, Herne, Germany

  • Local Institution - 0027, München, Germany

  • Local Institution - 0059, Dublin, Ireland

  • Local Institution - 0062, Dublin, Ireland

  • Local Institution - 0139, Verona, Veneto, Italy

  • Local Institution - 0073, Milan, Italy

  • Local Institution - 0087, Napoli Campania, Italy

  • Local Institution - 0180, Kobe, Hyōgo, Japan

  • Local Institution - 0179, Shiwa-gun Yahaba-cho, Iwate, Japan

  • The Cancer Institute Hospital of JFCR, Koto-ku, Tokyo, Japan

    Contact: Study coordinator (Yuji Miura) · 81335200111
  • Local Institution - 0078, Toyoma, Toyama, Japan

  • Kyushu University Hospital, Fukuoka, Japan

    Contact: Study coordinator (Tokiyoshi Tanegashima) · 0926425615
  • Local Institution - 0181, Niigata, Japan

  • Local Institution - 0046, Monterrey, Nuevo León, Mexico

  • Local Institution - 0048, Oaxaca City, Mexico

  • Local Institution - 0122, Puebla City, Mexico

  • Local Institution - 0049, Tlalpan, Mexico

  • Local Institution - 0108, Tlalpan, Mexico

  • Local Institution - 0118, Tlalpan, Mexico

  • Local Institution - 0103, Cluj-Napoca, Romania

  • Local Institution - 0161, Craiova, Romania

  • Local Institution - 0100, Iași, Romania

  • Local Institution - 0101, Sibiu, Romania

  • Local Institution - 0112, Seoul, Seoul-teukbyeolsi [Seoul], South Korea

  • Local Institution - 0017, Seoul, Seoul-teukbyeolsi, South Korea

  • Local Institution - 0167, Seoul, South Korea

  • Local Institution - 0013, Madrid, Spain

  • Local Institution - 0091, Madrid, Spain

  • Local Institution - 0043, Seville, Spain

  • Kantonsspital Graubünden, Chur, Switzerland

    Contact: Study coordinator (Richard Cathomas) · 41812566646
  • HOCH Health Ostschweiz, Sankt Gallen, Switzerland

    Contact: Study coordinator (Tobias Peres) · 0767931903
  • UniversitätsSpital Zürich, Zurich, Switzerland

    Contact: Study coordinator (Anja Lorch) · 492118108776
  • Royal Marsden Hospital (Chelsea), London, Kensington and Chelsea, United Kingdom

    Contact: Study coordinator (James Larkin) · 442078082132
  • St Bartholomew's Hospital, London, London, City of, United Kingdom

    Contact: Study coordinator (Thomas Powles) · 02078228498
  • Local Institution - 0186, Preston, North West, United Kingdom

  • Local Institution - 0022, Cambridge, United Kingdom

  • Velindre Cancer Centre, Cardiff, United Kingdom

    Contact: Study coordinator (Satish Kumar) · 442920615888
  • Local Institution - 0061, Edinburgh, United Kingdom

  • The Christie NHS Foundation Trust, Manchester, United Kingdom

    Contact: Study coordinator (Tom Waddell) · +441619187217
  • Royal Marsden Hospital Sutton, Sulton, Surrey, United Kingdom

    Contact: Study coordinator (James Larkin) · 442078082132
מובילי המחקר
  • Bristol-Myers Squibb

    Study Director

    Bristol-Myers Squibb